HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

P&G Business Realignment Combines Healthcare With Baby, Family Units

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Procter & Gamble will consolidate its health, baby and family care units as a single entity under new leadership as part of a strategic realignment announced May 19

You may also be interested in...



P&G Management Moves; Health, Beauty Grouped Together Under Arnold

Procter & Gamble brands such as Prilosec OTC and Crest will now fall under the supervision of Vice Chair-Beauty & Health Susan Arnold as part of management changes announced April 17

P&G Thinks Globally, Acts Locally With Long-Term Growth Strategy

Procter & Gamble has its eye on broadening its reach in key developing markets as it pursues its comprehensive global growth strategy

P&G Healthcare Business Has $10 Bil. Potential – CEO Lafley

Procter & Gamble's healthcare unit could generate in excess of $10 bil. annually within a few years, according to CEO A.G. Lafley

Table

View full table

Related Content

Pink Sheet

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Prestige Expands UK Eye Care Range In Response To Consumer Demand

See All
UsernamePublicRestriction

Register

RS128443

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By